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Background: Gold nanoparticles (AuNPs) demonstrate clinical potential for drug delivery and 
imaging diagnostics. As AuNPs aggregate in physiological fluids, polymer-surface modifications 
are utilized to allow their stabilization and enhance their retention time in blood. However, the impact 
of AuNPs on blood vessel function remains poorly understood. In the present study, we investi-
gated the effects of AuNPs and their stabilizers on endothelial cell (EC) and vasodilator function.
Materials and methods: Citrate-stabilized AuNPs (12±3 nm) were synthesized and surface-
modified using mercapto polyethylene glycol (mPEG) and polyvinylpyrrolidone (PVP) polymers. 
Their uptake by isolated ECs and whole vessels was visualized using transmission electron 
microscopy and quantified using inductively coupled plasma mass spectrometry. Their biological 
effects on EC proliferation, viability, apoptosis, and the ERK1/2-signaling pathway were 
determined using automated cell counting, flow cytometry, and Western blotting, respectively. 
Endothelial-dependent and independent vasodilator functions were assessed using isolated 
murine aortic vessel rings ex vivo.
Results: AuNPs were located in endothelial endosomes within 30 minutes’ exposure, while their 
surface modification delayed this cellular uptake over time. After 24 hours’ exposure, all 
AuNPs (including polymer-modified AuNPs) induced apoptosis and decreased cell viability/
proliferation. These inhibitory effects were lost after 48 hours’ exposure (except for the 
PVP-modified AuNPs). Furthermore, all AuNPs decreased acetylcholine (ACh)-induced 
phosphorylation of ERK1/2, a key signaling protein of cell function. mPEG-modified AuNPs 
had lower cytostatic effects than PVP-modified AuNPs. Citrate-stabilized AuNPs did not alter 
endothelial-dependent vasodilation induced by ACh, but attenuated endothelial-independent 
responses induced by sodium nitroprusside. PVP-modified AuNPs attenuated ACh-induced 
dilation, whereas mPEG-modified AuNPs did not, though this was dose-related.
Conclusion: We demonstrated that mPEG-modified AuNPs at a therapeutic dosage showed 
lower cytostatic effects and were less detrimental to vasodilator function than PVP-modified 
AuNPs, indicating greater potential as agents for diagnostic imaging and therapy.
Keywords: nanoparticles, gold, vascular, vasodilation, artery, cell culture
Plain-language summary
Gold nanoparticles have great clinical potential for drug delivery and imaging diagnostics. They 
are injected into the bloodstream to help diagnose and treat a number of conditions, including 
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cancer and vascular disease. Blood vessels are lined on the inside 
by cells that release mediators, which are essential for maintaining 
vessel health and in controlling vessel diameter to ensure that blood 
supply to tissues and organs matches demand. The nanoparticles 
were coated with polymer material to prevent their aggregation 
(clumping) and enhance their retention time in blood. The purpose of 
our work was to understand what effects gold nanoparticles and their 
coatings have on the function of blood vessels. We incubated iso-
lated cells and vessels with coated gold nanoparticles and polymer 
coatings over short periods at the therapeutic dose currently used in 
animal/clinical studies. We demonstrate that gold nanoparticles are 
rapidly taken up by cells lining blood vessels. We also demonstrate 
that gold nanoparticles and their coatings affect the function of cells 
and dilation of blood vessels. Our study will help guide clinicians 
on the use of gold nanoparticles and type of coatings that has least 
damaging effects on blood vessels.
Introduction
Gold nanoparticles (AuNPs) present a growing potential 
modality in biomedical research and clinical applications. 
As carriers of small biological compounds (eg, RNA, proteins, 
drugs), AuNPs can be engineered to enable targeting for the 
treatment of such conditions as diabetes, cancer, and vascular 
diseases through drug delivery and in diagnostic imaging as 
contrast agents.1,2 For example, AuNPs have been utilized 
in clinical trials for the treatment of lung and more recently 
prostate cancer. These comprise a 1–3 nm gold core with a 
100–120 nm silica shell, designed for precise thermal ablation 
of tumors following stimulation with a near-infrared energy 
source.1,3 Due to the high tendency of AuNPs to aggregate 
in solution,4 they are citrate-stabilized and often surface-
modified using organic polymer coatings. These polymers 
are hydrophilic chain-structured macromolecules that allow 
the AuNPs to remain well dispersed even at high salt con-
centrations. The polymers cause steric repulsion and prevent 
aggregation of the colloid particles, making them good 
stabilisers.5 These include thiolated mercapto polyethylene 
glycol (mPEG) and polyvinylpyrrolidone (PVP). Aurimune 
(CYT6091) is a novel AuNP currently planned for Phase II 
clinical trials for the treatment of late-stage cancer.6 Colloidal 
AuNPs (27 nm) have been surface-modified with PEG and 
tagged with TNFα to enable targeted delivery to tumors.7 
As potential drug-delivery and imaging modalities, AuNPs 
are hence injected intravenously into the bloodstream.1 
As such, endothelial cells (ECs) lining blood vessels consti-
tute the first site of exposure to these NPs. ECs play central 
roles in hemostasis and the modulation of blood vessel 
function through the release of mediators, in particular vaso-
dilators, such as nitric oxide (NO), which has key antithrom-
bogenic properties to help maintain vascular health.
Although AuNPs have been documented as biocompatible 
and nontoxic for cells,8,9 evidence suggests that they can 
affect EC viability and function,10 inducing apoptosis, 
upregulation of inflammatory mediators,11 and affecting 
signal-transduction pathways, including reduced phosphory-
lation of ERK1/2, and Akt/PKB, which are necessary for cell 
function.12,13 Furthermore, AuNPs can induce oxidative stress 
and generate reactive oxygen species, which can quench NO, 
thus affecting vascular function.14,15 The cytotoxic effects of 
AuNPs have been shown to be dependent on cell type, NP 
size, shape, dosage, and in particular, surface chemistry.15,16 
The importance of AuNP-surface modification has thus 
been highlighted, eg, PEG surface modification of 50 nm-
length gold nanorods has been shown to reduce EC death in 
comparison to polyelectrolyte capping.17 In addition, PVP is 
widely accepted as a biocompatible polymer material.18 For 
example, in vitro culture studies examining the influence 
of PVP coating on the immunotoxicity of graphene oxide 
have suggested that T-lymphocyte apoptosis is significantly 
delayed and less immunogenic than pure graphene oxide.19 
However, the impact of AuNP stabilizers on the viability 
of ECs and the function of healthy blood vessels remains 
poorly investigated. The aim of the present study was to 
determine the influence of AuNPs and their stabilizers on 
EC and vasodilator function of isolated aortic murine vessels 
ex vivo, in order to inform their safe clinical use.
Materials and methods
reagents and drugs
All reagents were obtained from Sigma-Aldrich (St Louis, 
MO, USA), unless otherwise stated. Physiological salt 
solution (PSS) was prepared using the following chemical 
composition (mM): 119 NaCl, 4.7 KCl, 1.2 MgSO
4
⋅7 H
2
O, 
25 NaHCO
3
, 1.17 KH
2
PO
4
, 0.03 K
2
EDTA⋅2H
2
O, 5.5 glucose, 
and 1.6 CaCl
2
⋅2H
2
O, pH 7.4. Potassium PSS (KPSS; 60 mM) 
was prepared using the following chemical composition 
(mM): 78.2 NaCl, 60 KCl, 1.2 MgSO
4
⋅7 H
2
O, 25 NaHCO
3
, 
1.17 KH
2
PO
4
, 0.03 K
2
EDTA⋅2H
2
O, 5.5 glucose and 
1.6 CaCl
2
⋅2H
2
O, pH 7.4, as previously described.20
synthesis and characterization of PVP 
and mPEG-modified gold NPs
Monodispersed AuNPs (12±3 nm) were synthesized according 
to Turkevich et al’s method (using chloroauric acid Au3+ 
reduced by sodium citrate)21 and characterized by transmis-
sion electron microscopy (TEM). PVP-modified AuNPs were 
prepared by dissolving 0.0036 g of PVP (molecular weight 
8,000 Da) in 1 mL deionized H
2
O, and 500 µL stock was left 
to stir with the gold seeds for 24 hours. The mPEG-modified 
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AuNPs were prepared by adding 0.125 mL (from a stock of 
1.44×10-5 g/mL of mPEG molecular weight 5,000 Da) to 
0.5 mL AuNPs and left to stir for 24 hours. To check the 
stability of the synthesized AuNPs after dispersion in PSS, 
water, or complete medium, samples were characterized 
by assessing their ultraviolet (UV)-visible spectra using a 
spectrophotometry. Fourier-transform infrared spectros-
copy (FTIR)/diffuse reflectance infrared FT spectroscopy 
(DRIFTS) were performed to determine the fingerprints 
of the polymer-modified AuNPs and their stabilizers. 
A background spectrum was initially run using Omnic 
software (Thermo Fisher Scientific) before samples were 
analyzed. Additionally, the functional groups attached on the 
polymer-modified AuNPs were analyzed by surface-enhanced 
Raman scattering.
cell-culture studies
Bovine aortic ECs (BAECs) were previously isolated and 
cultured as described by Sattar et al,22 in accordance with 
Manchester Metropolitan University’s institutional review 
board guidelines and ethics committee approval (FAETC/09-
10/19). Cells were cultured in complete medium composed of 
DMEM (Thermo Fisher Scientific) supplemented with 15% 
heat-inactivated FBS (ICN Biochemicals, Basingstoke, UK), 
2 mM glutamine, and antibiotics (100 µg/mL streptomycin 
and 100 IU/mL penicillin) into a 75 cm2 flask precoated with 
0.1% gelatin. BAECs were incubated at 37°C in 5% CO
2
 
and 95% saturated atmospheric humidity. Every 2–3 days, 
cells were passaged following enzymatic digestion with 
0.05% trypsin–0.02% EDTA and split at a ratio of 1:2 or 1:3. 
At confluence, BAECs were characterized by their typical 
cobblestone morphology. The cells were used throughout 
the study between passages 4 and 9. Cells were exposed to 
AuNPs at 2.9 µg/mL.
To assess EC proliferation, viability, and apoptosis, 
BAECs (4×104 cells/well) were seeded in complete medium 
in a 24-well plate. After 4 hours’ incubation, the medium was 
replaced with serum-poor medium (SPM; medium supple-
mented with 2.5% FBS to reduce adsorption of unknown 
serum proteins on AuNP surface) with or without AuNPs, and 
concentration determined by preliminary studies. After 24 
and 48 hours of incubation, cells were detached using 0.05% 
trypsin–0.02% EDTA and counted using a Beckman Coulter 
counter (Brea, CA, USA). Each condition was performed in 
triplicate and each experiment repeated three times.
Flow-cytometry analysis was used to assess cell viability 
based on the exclusion of the nonvital membrane impermeant 
DNA dye propidium iodide (PI) conjugated to phycoerythrin 
(PE) staining using the FL3 channel on a FACScan instrument. 
Viable cells corresponding to the PI-unstained cell samples 
prior to analysis were then set on stop count and examined 
on a forward scatter versus FL3 (PI) dot-plot staining. 
Normalization of the data was done using fluorescence-
activated cell-sorting (FACS) software and related to the 
unstained cells.
For the study of apoptosis and necrosis, cells were 
treated with 1 µg/mL staurosporine, a potent proapoptotic 
protein-kinase inhibitor. The positive control (staurosporine-
treated cells) was used to determine whether cells underwent 
apoptosis after exposure to modified and unmodified AuNPs 
along with their stabilizers after 2 and 24 hours of incubation. 
Cells were stained as described in an annexin V–fluorescein 
isothiocyanate (FITC) apoptosis-detection kit containing 
PI-PE. Apoptotic cells were characterized by the binding of 
annexin V to phosphatidylserine residues exposed to the outer 
membrane due to the loss of membrane integrity, also defined 
as annexin V+/PI- cells. Necrotic cells were characterized by 
annexin V in conjunction with the binding of PI as an indica-
tor of the loss of plasma and nuclear membrane integrity, also 
defined as annexin V+/PI+ (late apoptotic/necrotic cells) and 
annexin V-/PI+ (necrotic cells). The percentage of apoptotic 
or necrotic cells was obtained using the flow-cytometry 
analysis software. Each experiment was repeated at least 
three times. The fate of internalized AuNPs in BAECs was 
determined by TEM. After AuNP incubation, cells were fixed 
with 2% paraformaldehyde and processed. Ultrathin 70 nm 
sections were cut, placed on copper grids and observed using 
TEM (Tecnai 12 BioTwin at 80 kV).
For Western blot analysis, BAECs (6×105 cells/well) 
were seeded in complete medium in a six-well plate. After 
48 hours of incubation, the medium was renewed with SPM 
for a further 24 hours’ incubation, then AuNPs, AuPVP, PVP 
(5.9×10-7 µM), AumPEG, or mPEG (9.25×10-9) were added 
for 10 minutes’ exposure. Cell-lysate preparation, protein 
separation (by 12% sodium dodecyl sulfate-polyacrylamide 
gel electrophoresis), and transfer of separated proteins onto 
nitrocellulose membranes were performed as previously 
described.23 Nitrocellulose membranes were then stained 
with the following primary antibodies, overnight on a rotating 
shaker: mouse monoclonal antibodies to phospho-ERK1/2 
(p-ERK1/2, Tyr204 of ERK1, 1:1,000 dilution) and rabbit 
polyclonal antibodies to total ERK1/2 (C-16) (t-ERK1/2; 
1:1,000 dilution), provided by Santa Cruz Biotechnology. 
After being washed five times for 10 minutes in TBS–Tween 
at room temperature, filters were stained with either rabbit 
antimouse or goat antirabbit HRP-conjugated secondary 
antibodies diluted in TBS–Tween containing 5% defatted 
milk (1:1,000 dilution) for 1 hour at room temperature with 
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continuous shaking. After a further five washes in TBS–
Tween, proteins were visualized using electrochemilumi-
nescence detection (GE Healthcare UK, Little Chalfont, UK) 
and analyzed using GeneSnap software with the GeneTools 
image analyzer (Syngene, Cambridge, UK).
Vascular function studies
Segments of aortae (from male Wistar rats) were freshly 
isolated and surrounding perivascular fat carefully removed 
under a dissecting microscope (following institutional 
approval FAETC/09-10/19) in accordance with guidelines 
issued by the European Commission (directive 86/609/EEC). 
Aortic rings (2–3 mm in length) were cut, then suspended 
between two fine steel wires and placed in an oxygenated 
organ bath containing PSS. The rings were then loaded pas-
sively to 2 g tension to stabilize over 1 hour using a Harvard 
isometric transducer. Vessels were preconstricted with 
KPSS and dilated using the endothelium-dependent agonist 
acetylcholine (ACh; 0.01–100 µM) before and after incuba-
tion with AuNPs (2.9 µg/mL) for 30 minutes. The influence 
of polymers alone (10 nM–0.1 µM) on dilator function was 
also examined.
The presence of modified and unmodified AuNPs within 
the aortic vessels after 30 minutes’ incubation was deter-
mined using inductively coupled plasma mass spectrometry 
(ICP-MS; PerkinElmer, Waltham, MA, USA). Briefly, the 
vessel was firstly weighed before incubation with the experi-
mental conditions (AuNPs, AumPEG, or AuPVP). Vessel 
weight was recorded and lysate buffer (0.5 mL containing 
0.5 g sodium dodecyl sulfate, 0.2925 g NaCl, 0.394 g tris, 
0.03 g tris[hydroxylmethyl]aminomethane) was added for 
48 hours at room temperature. Each tube was mixed with 
1 mL high-purity (70%) nitric acid to dissolve the vessel. 
Glass tubes were placed in an oil bath at 200°C for 3 hours 
and analyzed.
statistical analysis
For vascular function studies, results are expressed as 
mean ± SEM, and one-way analysis of variance with 
Bonferroni correction test was used for comparison of two 
groups. For cellular studies, an unpaired Student’s t-test was 
used for comparison of two groups, and results are expressed 
as means ± SD. For each test applied, a value of P,0.05 was 
considered significant.
Results
characterization of gold NPs
TEM of unmodified AuNPs showed they were monodis-
persed (12±3 nm in diameter) and spherical (Figure 1A). 
The addition of organic polymer-composite coatings (PVP 
and mPEG) did not affect the overall size or sphericity of 
AuNPs. With UV-visible spectroscopy, it was possible to 
identify the characteristic plasmon resonance peak at 525 nm 
wavelength. As the surface-plasmon position is very sensitive 
to surface interactions, any NP aggregation can result in loss 
of the plasmon peak, and hence aggregation was assessed 
using plasmon absorption. UV-visible spectra confirmed that 
the unmodified AuNPs were stable in the presence of ultra-
pure water. The characteristic plasmon resonance peak was 
identified at 525 nm wavelength; however, when dispersed 
in PSS the peak was lost, indicating particle aggregation. The 
plasmon resonance peak was also evident when the PVP- and 
mPEG-modified AuNPs were suspended in both water and 
PSS, demonstrating that AuNPs were stable after surface 
modification using polymers (Figure 1B). Furthermore, both 
modified and unmodified AuNPs were stable in DMEM cell-
culture media; however, the slight shift in the plasmon peak 
indicated that there was a change in the NP-surface environ-
ment (due to the presence of proteins that are likely to have 
adsorbed on to the AuNP surface [Figure 1C]).
FTIR-DRIFTS spectra of PVP- and mPEG-modified 
AuNPs were compared with spectra from PVP and mPEG 
alone. PVP peaks at 1,660 cm-1 and 1,200 cm-1 corresponded 
to the C=O and C-N vibrations in PVP. Absorption peaks 
at 1,650 cm-1 and 1,641 cm-1 are characteristics of pyrro-
lidinyl groups in PVP.24 These were also observed on the 
PVP-modified AuNPs, confirming surface functionaliza-
tion. Evidence for mPEG functionalization of the AuNPs 
was demonstrated by characteristic absorption in mPEG at 
1,103 cm-1, corresponding to C-O-C vibration, and the peak 
at 1,641 cm-1 corresponds to the C=O from the residual citrate 
groups still present.25 The C=O vibration at 1,637 cm-1 identi-
fied upon analysis of the citrate-stabilized AuNPs relates to 
the presence of sodium citrate26 (Figure 2). The functional 
groups on our AuNPs were also confirmed using surface-
enhanced Raman spectroscopy analysis (Figure S1).
effect of gold NPs on isolated endothelial 
cells in vitro
TEM clearly demonstrated the uptake of both unmodified and 
modified AuNPs by cultured BAECs at different incubation 
times (Figure 3). After 2 hours of cell exposure, there was an 
increase in AuNP uptake (32±5 AuNPs) compared to the low 
number observed after 30 minutes’ exposure (5±0 AuNPs). 
Interestingly, there was a greater number of AuNPs and 
AuPVP internalized by the cells after 24 hours (638±156 
and 233±92, respectively). However, after 48 hours of cell 
exposure, there was a higher uptake of AuPVP (700±92), 
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but significantly less uptake of AumPEG (16±4). Both modi-
fied and unmodified AuNPs were observed to be localized in 
endosomes within the cytoplasm (Figure 3). AuNP uptake had 
no influence on the standard polygonal shape of the cells.
In the absence of AuNPs, there was no significant change 
in cell proliferation after 48 hours’ exposure compared 
with the control (untreated cells) obtained after 24 hours’ 
exposure. The addition of unmodified AuNPs significantly 
decreased cell proliferation after 24 and 48 hours (P,0.001 
and P=0.01, respectively). When the BAECs were exposed to 
PVP-modified AuNPs, significant inhibition (30%, P,0.01) 
was observed after 24 hours (Figure 4). Similarly, there was 
significant inhibition in cell proliferation when BAECs were 
exposed to the composite polymers PVP (2.04×10-7 g/mL, 
P,0.01), PEG (4 µg/mL, P=0.01), mPEG (7.4×10-8 g/mL, 
P,0.001), and modified AuNPs, including AuPVP and 
AumPEG (P,0.001), after 24 hours. In contrast to AuNPs, 
the inhibitory effects of modified AuNPs on cell prolifera-
tion were reduced after 48 hours’ exposure when compared 
with the control.
We determined the viability of BAECs using FACS fol-
lowing exposure to modified and unmodified AuNPs and 
their stabilizers after 30 minutes and 2, 24, and 48 hours. 
In the absence of AuNPs, short (30 minutes and 2 hours) and 
long (24 and 48 hours) exposure did not affect the high cell 
viability (around 95%) compared with the control (untreated 
cells at 30 minutes). The addition of unmodified and modified 
AuNPs to SPM slightly decreased cell viability by 5% after 
30 minutes’ exposure, with a further decrease by 5% after 
2 hours’ exposure followed by 20% reduction in cell viability, 
compared with the respective control (untreated cells after 
30 minutes and 2 and 24 hours) (Figure 5). After 48 hours’ 
exposure, unmodified and mPEG-modified AuNPs lost their 
inhibitory effect on cell viability observed after 24 hours’ 
exposure, which displayed high cell viability compared with 
untreated cells (Figures 5 and S2).
The apoptotic and necrotic status of BAECs were deter-
mined by flow-cytometry analysis through the double stain-
ing of annexin V–FITC and nonvital dye PI-PE. Untreated 
cells were defined as a negative control and staurosporine, 
Figure 1 gold nanoparticle (auNP) synthesis and characterization.
Notes: (A) Transmission electron micrography of spherical monodispersed citrate-stabilized auNPs (12±3 nm); (B, C) Ultraviolet-visible absorbance spectra of auNP 
stability after modification with PVP and mPEG in physiological salt solution (PSS) and culture media.
Abbreviations: PVP, polyvinylpyrrolidone; mPeg, mercapto polyethylene glycol.
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a protein-kinase inhibitor, used as a positive control for induc-
tion of apoptosis. After 2 hours’ exposure, the cell population 
treated with modified and unmodified AuNPs displayed about 
30%–40% apoptotic cells compared to 1%–3% within untreated 
cells (Figure 6). A decrease in the percentage of apoptotic 
cells was observed after 24 hours of cell exposure to AuNPs, 
while the percentage of apoptotic cells was increased slightly 
in the presence of either polymer composites or modified 
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Figure 2 FTIR spectra for stabilizers and unmodified and modified AuNPs.
Note: (A) PVP, (B) auPVP, (C) mPeg, (D) aumPeg, and (E) auNPs, illustrating characteristic absorption peaks.
Abbreviations: FTIr, Fourier-transform infrared spectroscopy; auNPs, gold nanoparticles; PVP, polyvinylpyrrolidone; mPeg, mercapto polyethylene glycol.
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AuNPs (Figure 6). No necrotic cells were detected after 2 hours’ 
incubation with polymer composites or unmodified/modified 
AuNPs, but 45% necrotic cells were determined when exposed 
to PVP compared with the control (untreated cells) (Figure 6). 
This PVP necrotic effect mostly disappeared with exposure 
time, as a weak necrotic effect was detected compared with the 
control (untreated cells) (Figure 6). In contrast to PVP necrotic 
effect, after 24 hours’ exposure, the cell population treated 
with mPEG displayed about 30% necrotic cells compared 
to 18% within untreated cells (control) (Figures 6 and S2).
KRXUV
KRXUV
PLQXWHV
,QFXEDWLRQWLPH
KRXUV
$XP3(* $X393$X13V
QP QP QP
QP QP QP
QP QP QP
QP QP QP
Figure 3 gold nanoparticle (auNP) uptake by Baecs in culture.
Notes: Transmission electron micrographs showing the time course of AuNP uptake (citrate-stabilized and mPEG- and PVP-modified) by BAECs. AuNPs are identified as 
spherical structures inside endosomes within the endothelial cells (arrows).
Abbreviations: Baecs, bovine aortic endothelial cells; mPeg, mercapto polyethylene glycol; PVP, polyvinylpyrrolidone.
&RQWURO






$X13V
1XP
EHU
RIF
HOOV
ZH
OO


  
  

$X393 393 3(* P3(* $XP3(*
KRXUV KRXUV
&RQGLWLRQV
Figure 4 Inhibitory effects of stabilizers and unmodified and modified AuNPs on BAEC proliferation.
Notes: **P,0.01; ***P,0.001. results presented as mean ± sD. Three independent experiments.
Abbreviations: auNPs, gold nanoparticles; Baec, bovine aortic endothelial cell; mPeg, mercapto polyethylene glycol; PVP, polyvinylpyrrolidone.
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To check the functional integrity of the endothelium, cul-
tured BAECs were exposed to various concentrations of the 
endothelium-dependent vasodilator ACh (1, 10, and 100 µM) 
for 10 minutes. Mediated through muscarinic receptors, ACh 
has been demonstrated to induce several signaling pathways, 
including the survival pathway involving ERK1/2. The 
effect of ACh concentrations on ERK1/2 phosphorylation 
was assessed by Western blot analysis. When compared 
to untreated cells (control), ACh concentrations induced 
phospho-ERK1/2 expression at all concentrations used, 
with a peak of stimulation attained in the presence of 10 µM 
ACh (fivefold increase) (Figure 7A). As NPs have been 
suggested to influence the phosphorylation or dephosphory-
lation of regulatory proteins involved in vascular function, 
Figure 5 The influence of stabilizers and unmodified and modified AuNPs on BAEC viability using flow cytometry.
Notes: *P,0.05; **P,0.01. Percentage cell viability of BAECs in the untreated cells and cells treated with stabilizer (PVP), non-modified and modified AuNPs (AuPVP, 
aumPeg) after 30-minute and 2–24- and 48-hour exposure based on three independent experiments. results presented as mean ± sD.
Abbreviations: auNPs, gold nanoparticles; Baec, bovine aortic endothelial cell; PVP, polyvinylpyrrolidone; mPeg, mercapto polyethylene glycol.
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Figure 6 Induction of apoptosis and necrosis by stabilizers and unmodified and modified AuNPs in BAECs.
Notes: *P,0.05; **P,0.01; ***P,0.001. apoptosis (A) and necrosis (B) of BAECs in untreated cells and cells treated with stabilizer (PVP) and unmodified and modified 
auNPs (auPVP, aumPeg) after 2- and 24-hour exposure based on three independent experiments. results presented as mean ± sD.
Abbreviations: auNPs, gold nanoparticles; Baecs, bovine aortic endothelial cells; PVP, polyvinylpyrrolidone; mPeg, mercapto polyethylene glycol.
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we investigated the potential modulatory effects of polymer-
modified AuNPs on ACh-stimulated ECs. BAECs were 
thus exposed to 10 µM ACh in the presence of modified 
and unmodified AuNPs to assess ERK1/2 phosphorylation 
subsequently. Both unmodified and modified AuNPs, as well 
as polymers alone or combined with ACh, caused a reduction 
in ERK2 phosphorylation when compared to ACh-induced 
phospho-ERK2 expression (Figure 7B). A significant reduc-
tion in expression was observed after AuPVP, PVP, and 
AumPEG incubation (P,0.05).
effect of gold NPs on vascular function
TEM indicated that the unmodified AuNPs had aggregated 
and were located within the lumen of the vessel. They were 
seen close to the surface of ECs. There was no evidence that 
AuNPs had entered the cell. On the other hand, PVP-modified 
NPs were identified within ECs. They were located within 
endosomal structures, but not freely within the cytoplasm, 
suggesting that uptake was by the process of endocytosis. 
Very few mPEG-modified AuNPs were identified in ECs 
when added at 2.9 µg/mL. However, once the NP concentra-
tion was increased, greater uptake was detected (Figure 8). 
ICP-MS analysis indicated a high degree of uptake of 
unmodified AuNPs (0.45 ppm, 13.95%) compared to PVP 
(0.14 ppm, 4.4%) and mPEG-modified NPs at 2.9 µg/mL. 
At 5.8 µg/mL, both uptake of PVP- (0.38 ppm, 6.46%) and 
mPEG- (0.35 ppm, 6.07%)-modified AuNPs increased, 
but was nonetheless still lower than that of the unmodified 
AuNPs (highest uptake at 0.74 ppm, 23.95%) (Figure 8).
All vessels constricted to high-potassium PSS (60 mM, 
KPSS). There was no significant difference in the degree 
of constriction after vessels were incubated in unmodified 
AuNPs (2.31±0.28 g/tension, n=5), PVP-modified AuNPs 
(2.31±0.35 g/tension, n=5), mPEG-modified AuNPs 
(2.26±0.18 g/tension, n=5), PVP alone (2.312±0.139 g/tension, 
n=5), PEG alone (2.71±0.13 g/tension, n=5), or mPEG alone 
(2.57±0.18 g/tension, n=5) compared to PSS (2.00±0.124 
g/tension, n=5).
ACh and sodium nitroprusside (SNP) induced a 
concentration-dependent dilator response in all precon-
stricted vessels. Incubation with citrate-stabilized AuNPs 
had no overall effect on ACh-induced endothelial-dependent 
dilator responses (n=5), but significantly reduced SNP-
induced dilator responses (Figure 9). PVP-modified AuNPs 
had no overall influence on endothelial-dependent dilator 
responses. However, PVP alone (at 5.9×10-7 µM, identified 
as the minimum concentration required to prevent aggrega-
tion) caused a significant reduction in ACh dilator responses 
at 10–100 µM (ACh) (P,0.05) when compared to PSS. 
Vessel incubation in AuPVP affected SNP dilator responses; 
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Figure 7 Modulatory effects of stabilizer and unmodified and modified AuNPs on ACh-induced ERK1/2 phosphorylation in BAECs.
Notes: (A) representative Western blot analysis (a1) showing the stimulatory effect of 1/10/100 µM ach on erK1/2 phosphorylation (p-erK1/2) in Baecs after 10 minutes’ 
exposure compared to untreated cells (control); relative expression of p-erK1/2 calculated as a ratio to erK1/2 expression, the loading control (a2). (B) representative 
Western blot analysis (B1) showing the modulatory effects of 10 µM ach-induced erK1/2 phosphorylation in the absence or in the presence of stabilizer (PVP) and 
non-modified and unmodified AuNPs (AuPVP, AumPEG) in BAECs after 10 minutes’ incubation compared to untreated cells (control). The bar graph shows the relative 
expression of p-erK1/2 calculated as a ratio to erK1/2 expression, the loading control (B2).
Abbreviations: auNPs, gold nanoparticles; ach, acetylcholine; Baecs, bovine aortic endothelial cells; PVP, polyvinylpyrrolidone; mPeg, mercapto polyethylene glycol; 
t-erK, total erK.
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a significant reduction in dilator response was obtained at 
0.001–0.01 µM (SNP, P,0.001), with a further reduction at 
0.1 µM (P,0.01). PVP alone led to a small reduction in SNP 
responses (Figure 9). There was no significant attenuation 
in ACh responses after incubation with mPEG-modified 
AuNPs. Incubation in PEG alone had no overall effect on 
ACh dilator responses. mPEG-modified AuNPs at 2.9 µg/mL 
had no overall effect on SNP dilator responses (Figure 9). At a 
Figure 8 gold nanoparticle (auNP) uptake by aortic vessels.
Notes: (A) Determination of AuNP uptake using inductively coupled plasma analysis. Concentration of unmodified and polymer-modified AuNPs within aortic vessels after 
30 minutes’ exposure. error bars are seM. (B) Representative transmission electron micrography illustrating the uptake of PVP-modified AuNPs into endosomal structures 
(a; b at higher magnification), and also on the surface of endothelial cells lining the aortic vessel (c), within 30 minutes’ exposure. Very few mPEG-modified AuNPs are seen 
as spherical dense structures within the endothelial cells (d, arrow) when exposed to the higher concentration.
Abbreviations: PVP, polyvinylpyrrolidone; mPeg, mercapto polyethylene glycol.
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Attenuated vasodilation induced by PVP-modified AuNPs
higher concentration of 5.8 µg/mL, mPEG-modified AuNPs 
led to a significant reduction in dilator responses compared 
to PSS control at most ACh concentrations (Figure S3).
Discussion and conclusion
AuNP fabrication and surface modification remain a critical 
step to avoid aggregation and increase efficiency of drug 
release. In the present study, we demonstrated that surface 
modification of AuNPs reduced their uptake by ECs com-
pared to unmodified AuNPs within 30 minutes of exposure. 
We showed that mPEG-modified AuNPs had less inhibitory 
effects on EC proliferation, viability, and ACh-induced cell 
and vascular functions than PVP-modified AuNPs.
A slight change in the ionic strength of the microenviron-
ment, such as that observed in many bodily fluids (including 
blood plasma), is known to be the cause of AuNP aggregation, 
Figure 9 Influence of stabilizers and unmodified and modified AuNPs on dilator responses of aortic vessels.
Notes: *P,0.05; **P,0.01; ***P,0.001. endothelial-dependent (ach) and independent (sNP) dilator responses of preconstricted aortic vessels after 30 minutes’ exposure 
ex vivo. error bars are seM.
Abbreviations: auNPs, gold nanoparticles; ach, acetylcholine; sNP, sodium nitroprusside; PVP, polyvinylpyrrolidone; mPeg, mercapto polyethylene glycol.
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which leads to a shift in the surface-plasmon resonance peak. 
AuNP-surface modification using PVP and mPEG enables 
stearic stabilisation27,28 and significantly increases the stability 
of NPs in NaCl.29 Indeed, nanomaterials that are completely 
coated in PVP have been shown not to aggregate even at high 
salt concentration.30 PVP has been demonstrated to stabilize 
AuNPs by the interaction of the lone pair of electrons from 
nitrogen and oxygen atoms in its polar groups with the AuNP 
surface.31 In our present study, AuNP aggregation in PSS 
was the result of complex formation of citrate anions with 
Na+ cations in the PSS. The stability of unmodified AuNPs 
in cell-culture medium may be due to the presence of FBS 
and cellular proteins that absorb on the surface of AuNPs.27 
These provide stability to the AuNPs, as demonstrated by 
our UV-visible spectra, which did not show any loss of 
surface-plasmon resonance (at 525 nm) after exposure to the 
cell-culture medium.32 Evidence for PVP and mPEG func-
tionalization on AuNPs was confirmed using FTIR, as has 
been previously demonstrated.26 Surface-enhanced Raman 
scattering analysis also confirmed the presence of functional 
groups on surface-modified AuNPs.
In the present study, AuNPs were internalized within 
endosomal structures inside the cytoplasm of BAECs. We 
show that cellular uptake of AuNPs was dependent on incuba-
tion time and type of stabilizers used.27 This is in agreement 
with previous research that has also demonstrated that AuNP 
uptake is dependent on surface chemistry, size, shape, and 
dosage.27 Freese et al elegantly demonstrated the size- and 
coating-dependent uptake of AuNPs within ECs.33 While 
intracellular uptake of AuNPs has been shown to enhance 
the effects of radiation doses,34 the dynamics of uptake can 
vary depending on cell type and the physical dimensions 
of the AuNPs.35 By examining the kinetics of the uptake of 
14–100 nm spherical and rod-shaped AuNPs into HeLa cells, 
maximum uptake has been demonstrated for 50 nm AuNPs 
with a half-life of 1.9 hours.35 AuNP uptake by our ECs 
was evident within 30 minutes’ incubation, while uptake of 
polymer-modified AuNPs was observed only after 2 hours. 
In addition, the cellular uptake of AuNPs was reduced 
over time. This might have been due to cell division or due 
to AuNP expulsion from the cells over time, as has been 
observed previously.36 We found greater uptake of PVP-
modified AuNPs than mPEG-modified AuNPs. In contrast to 
PVP-modified AuNPs, the cellular uptake of mPEG-modified 
AuNPs was observed only after 24 hours of incubation. 
This is supported by the work of Nativo et al, who reported 
the absence of uptake of PEG-modified AuNPs by HeLa 
cells, even after prolonged incubation times or increased 
NP concentrations.27 Furthermore, Hu et al demonstrated 
that PEG coating resulted in reduction in cellular uptake 
by a third compared to another polymer coating (poly[N-
vinylcaprolactam]), which promoted the cellular uptake of 
NPs.28,37 While polymer coating for enhanced retention of 
AuNPs may be desirable for imaging diagnostics, targeted 
delivery to specific sites/cells may be achieved by surface 
modification using mixed PEG–peptide to enable receptor-
mediated endocytosis and enhance cellular internalisation.38 
The use of charged polymers containing aromatic sulfonate 
has also shown preferential endocytosis by ECs, due to their 
affinity for caveolae structures.39
We demonstrated that BAEC proliferation was inhibited 
after incubation with both unmodified AuNPs and polymer-
modified AuNPs, as has been previously demonstrated in 
human dermal microvascular ECs.33 In our present study, 
we showed that AuPVP and AumPEG had similar effects 
on BAEC proliferation and viability. We assessed apoptosis, 
also known as programmed cell death, using flow-cytometry 
analysis based on annexin V–FITC and PI-PE double stain-
ing, and found that AuNPs exerted significant effects in 
a time-dependent manner and were influenced by surface 
modification. Similarly, Selim and Hendi found that AuNPs 
induced apoptosis in MCF7 human breast cells via activation 
of the p53, Bax/Bcl2, and caspase pathways.40 However, 
they found that significant cytotoxicity was dose-dependent, 
whereby at 200 µg/mL viability was 70% after 24 hours. The 
latter dose used was threefold higher than the one used in our 
study (2.9 µg/mL). Here, we showed that modified AuNPs 
and their stabilizers, PVP and mPEG, induced a significant 
increase in apoptosis. We also observed that mPEG and PVP 
alone significantly increased necrotic cells. The influence 
of AuNPs on cell death and apoptosis has been documented 
previously,9,12 including PEG-modified AuNPs,41 whereby 
their accumulation in tissues after in vivo administration 
has also been shown to alter biochemical indices of liver 
and kidney damage41 and upregulates markers of acute 
inflammation.42 PVP-modified AuNPs have also been dem-
onstrated to inhibit MMP activity without any cytotoxic 
effects. The inhibitory effect is attributed to binding of the 
negatively charged surface PVP coating to Zn2+ moieties 
within MMPs.43
MAPK (ERK1/2) is necessary for induction of various 
cell functions, including proliferation, and its activated form 
(phospho-ERK1/2) is known to accumulate significantly in 
the nucleus.44 In addition, previous studies have demonstrated 
the importance of ERK2 phosphorylation over ERK1 phos-
phorylation in cell proliferation and survival.45 Our Western 
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blot analysis showed that ERK1/2 expression was reduced 
in all culture conditions when compared to incubation in 
ACh alone. Suppression of ERK1/2 phosphorylation by 
AuNPs has recently been documented in human umbilical 
vein ECs.13 This is also supported by our finding that both 
modified and unmodified AuNPs inhibited cell proliferation 
of BAECs. As inhibitors of the ERK1/2 pathway are emerg-
ing in clinical trials as anticancer agents,44 our modified/
unmodified AuNPs may have potential use as anticancer 
agents. Indeed, the antiangiogenic effects of AuNPs have 
recently been shown.13
Although unmodified AuNPs were not detectable inside 
ECs from the TEM images analyzed, we found evidence of 
their uptake using ICP-MS. A few AuNPs were detected 
after modification with mPEG and PVP, while an increase 
in concentration of mPEG-modified AuNPs led to increased 
vascular uptake. AuNPs were located in the cytoplasm of 
ECs, but none was located in the nucleus of cells, elastic 
lamina, or smooth-muscle cell layer. Reduced uptake of 
PEGylated NPs has been demonstrated previously and shown 
to reduce hydrophilicity, phagocytosis, and accumulation in 
off-target organs.46 Reduced NP uptake may also be due to 
the dynamics of uptake via endocytosis/exocytosis.9,36,47
Aortic vessels were incubated in AuNPs at 1.68×1011 NPs/
mL (equivalent to 2.9 µg/mL), over a 30-minute acute-exposure 
period. This dosage was also utilized in our cell-culture 
experiments. Our exposure time and NP concentration 
are commonly used in preclinical and clinical studies. Stern 
et al utilized gold-core NPs with a silica shell, infused at 
approximately 2.77×1011 NPs/mL, to ablate prostate tumors 
thermally.1 In preclinical studies, AuNPs have been iden-
tified within 30 minutes of intravenous administration 
into mice, in the dermal papilla and root sheaths of hair 
follicles.48 Intravenous injection of 13 nm PEGylated AuNPs 
(at 1.76×1011 NPs/mL) led to their accumulation in tissues 
within 30 minutes and induced acute inflammation and 
apoptosis.42 We observed that unmodified AuNPs had no 
overall effect on the endothelium-dependent (ACh) relax-
ation of the vessels; however, they significantly attenuated 
responses to the endothelium-independent agonist SNP. SNP 
has been used clinically as an antihypertensive agent, as it 
acts by releasing NO, leading to dilation of small vessels. 
AuNPs may interact directly with the SNP drug, as has 
been demonstrated previously in mesenteric vessels after 
incubation in quantum dots.49 Such interaction has also been 
suggested for a number of other agonists after pulmonary NP 
exposure,50 thus confirming the additional need for surface 
modification of AuNPs before use.
Vessel incubation in PVP-modified AuNPs had no 
significant effect on ACh dilator responses; however, incuba-
tion in PVP alone (at the minimum concentration required 
to prevent NP aggregation) caused a significant reduction in 
ACh responses. In comparison, vessel incubation in PVP-
modified AuNPs induced a significant reduction in SNP 
responses. When vessels were incubated in PVP alone, no 
significant effect on SNP responses was noted. This sug-
gests that it is the AuNPs themselves that may be interfering 
with the action of SNP. AuNPs and PVP-modified AuNPs 
may compete for the NO released by the NO donors, thus 
impairing the vasodilator response, as has been recently 
demonstrated using ruthenium complex as an NO donor. 
When complexed with AuNPs, NO release was reduced.51 
The PVP-polymer monolayer may have been insufficient to 
coat the AuNPs fully, and hence allowed their interaction 
with SNP. AuNPs have previously been demonstrated to 
show intrinsic catalytic activity,52 which can vary depending 
on their surface charge and the type of surface modification.53 
Using electrospin-resonance spectroscopy, He et al investi-
gated the catalytic activity of AuNPs and demonstrated that 
both PVP- and tannic acid-modified 10–100 nm AuNPs 
rapidly catalyzed the decomposition of hydrogen peroxide, 
generating hydroxyl radicals at low pH and oxygen at higher 
pH. This has important implications in relation to AuNP 
uptake into the acidic environment of endosomal structures 
within cells. The AuNPs were also able to scavenge reactive 
oxygen species, catalyzing the decomposition of superoxide 
anions.52 mPEG-modified AuNPs (at 2.9 µg/mL) had no 
overall influence on endothelium-dependent responses. When 
exposed to a higher 5.8 µg/mL concentration of mPEG-
modified AuNPs, dilatory responses were significantly 
reduced (P,0.001). Indeed, uptake of mPEG-modified 
AuNPs by ECs has also been shown to be concentration-
dependent by others, whereby high NP concentration may 
result in passive transport into vessels.54
In order to elucidate mechanisms leading to attenuated 
vasodilation by AuNPs, we conducted cellular studies to 
examine their influence on the ERK1/2-signaling pathway. 
This pathway plays an important role in stimulating the 
production of NO by activation of endothelial NO synthase, 
and has been implicated in vasodilator responses associated 
with retinal arterioles.55 When BAECs were stimulated with 
ACh, ERK1/2 phosphorylation was maximal at 10 µM ACh 
concentration, in accordance with maximal aortic vasodila-
tion, ex vivo. When BAECs were stimulated with ACh in 
the presence of modified and unmodified AuNPs, a reduc-
tion in ERK2 phosphorylation was observed for PVP and 
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mPEG-modified AuNPs. Vessel incubation in PVP alone 
led to a significant reduction in ACh-induced dilation. The 
reason for this is not clear. The surface chemistry of the 
polymers, however, is known to influence cell interaction 
and morphology.56,57 PVP-surface groups could bind to ACh 
receptors, acting as an antagonist.58 This is supported by the 
rightward shift in the ACh dose–response curve, observed 
in our study after PVP incubation.
Conclusion
We showed that AuNP uptake by cells was dependent on 
surface modification and incubation time. Incubation in 
polymers alone also affected cellular and vasodilator func-
tions. We showed that exposure of isolated aortic vessels to 
AuNPs at a dosage similar to that utilized in clinical trials1 
affected vasodilator function, but was dependent on surface 
modification. PVP surface-modified gold NPs inhibited EC 
viability, proliferation, and ERK1/2 phosphorylation, and 
reduced the magnitude of endothelial-independent dilator 
responses in aortic vessels. In contrast, mPEG-modified 
AuNPs showed lower cytostatic effects and were less detri-
mental to vasodilator function than PVP-modified AuNPs, 
indicating greater potential as agents for diagnostic imaging 
and therapy.
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Supplementary materials
surface-enhanced raman spectroscopy
For sample preparation, 1 mL gold nanoparticle (AuNP) 
solution was drop-coated on the glass slide and left to dry in 
the oven overnight, then Raman spectra were recorded the 
following day. The spectra were obtained with a microscopic 
confocal Raman spectrometry, operated with an argon laser 
(514 nm). The laser intensity was 50 mW. Surface-enhanced 
Raman spectroscopy analysis showed the vibration frequency 
of the functional groups on AuNPs, identified by the peaks 
of the groups present within Au polyvinylpyrrolidone 
(AuPVP) and Au mercapto polyethylene glycol (AumPEG) 
and the types of bonds present in the chemical compounds. 
The spectra showed that the AuNPs were functionalized, as 
the wavelength of the functional groups were identified and 
demonstrated to be present. The results indicated the shifting 
of the C=O peak from 1,521 cm-1 in the citrate-stabilized 
AuNPs to 1,649 cm-1, which was attributed to the hydrogen 
bonding between the mPEG and citrate ligands. The peak 
shifted to 1,609 cm-1 after the surface had been stabilized 
with PVP (Figure S1).
Flow cytometry
cell viability
Flow-cytometry analysis was performed after 30 minutes and 
2–24 and 48 hours of bovine aortic endothelial cell (BAEC) 
treatment with stabilizers and unmodified and modified 
AuNPs, followed by staining with propidium iodide (PI)–
phycoerythrin (PE). Representative dot blots are shown in 
Figure S2A.
cell apoptosis and necrosis
Flow-cytometry analysis was performed after 2 and 
24 hours of BAEC treatment with stabilizers and unmodi-
fied and modified AuNPs, followed by double staining with 
annexin V–fluorescein isothiocyanate/PI-PE (Figure S2B).
Vasodilator responses to mPEG-modified 
auNPs
In a separate set of experiments, the influence of a double 
concentration of mPEG-modified AuNPs (at 5.8 µg/mL) 
on vasodilator function was assessed. A significant reduc-
tion in acetylcholine-induced dilator function was observed 
(Figure S3).
Figure S1 Surface-enhanced Raman spectroscopy analysis for unmodified and modified AuNPs.
Note: Unmodified AuNPs (A), mPEG-modified AuNPs (B), and PVP-modified AuNPs (C).
Abbreviations: auNPs, gold nanoparticles; mPeg, mercapto polyethylene glycol; PVP, polyvinylpyrrolidone.
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Figure S2 Flow-cytometry analysis of cell viability, apoptosis, and necrosis after auNP exposure.
Notes: (A) cell viability of Baecs in untreated cells and in cells treated with aumPeg after 24 and 48 hours. Numbers within dot plots represent the percentage of live cells 
(lower left, PI-). (B) Induction of apoptosis by aumPeg after 2 hours’ exposure, showing induction of necrosis by stabilizers after 2 and 24 hours’ exposure in comparison 
with untreated cells.
Abbreviations: auNP, gold nanoparticle; Baecs, bovine aortic endothelial cells; mPeg, mercapto polyethylene glycol; PI, propidium iodide; Pe, phycoerythrin; PVP, 
polyvinylpyrrolidone.
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Figure S3 Influence of mPEG-modified AuNPs on endothelial-dependent dilator responses of aortic vessels.
Notes: *P,0.05; **P,0.01; ***P,0.001. endothelial-dependent (ach) dilator responses of preconstricted aortic vessels after 30 minutes’ exposure of high-concentration 
mPEG-modified AuNPs (5.8 µg/ml) ex vivo. error bars are seM.
Abbreviations: auNPs, gold nanoparticles; mPeg, mercapto polyethylene glycol; PVP, polyvinylpyrrolidone.
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